French | English
Home : Agenda

Agenda

Presentation of the consolidated results for 2009
04 March 2010, Company Head Office, Paris, France
ASHP (American Society of Health-System Pharmacists) 2009 Midyear Clinical Meeting - Posters: " Evaluation of miconazole mucoadhesive buccal tablet: A novel, once daily, antifungal regimen for the treatment of oropharyngeal candidiasis"; "Efficacy of miconazole mucoadhesive buccal tablets compared to clotrimazole troches for the treatment of oropharyngeal candidiasis: SMiLES trial"
06 December 2009, Las Vegas, US - 6-10 December, 2009
17th ESGCT (European Society of Gene & Cell Therapy) Annual Congress - Oral presentation: "Plasmid-AMEP: an efficient antiangiogenic and antitumor gene medicinal product for metastatic melanoma treatment"; Poster: "Muscle electrotransfer of Plasmid AMEP, a gene product for melanoma treatment, is safe and well tolerated in mice"
21 November 2009, Hannover, Germany - 21-25 November, 2009
AAPS (American Association of Pharmaceutical Scientists) 2009 Annual Meeting - Posters: "Oral Irinotecan sustained release nanoparticles: formulation optimization and in vitro release profile"; "Tolerance and anti-tumoral efficacy of oral Irinotecan Sustained Release nanoparticles formulation in HT29 xenograft mice model"; "Pharmacokinetic profile of an Irinotecan Sustained Release nanoparticles formulation"
09 November 2009, Los Angeles, US - November 9-12, 2009
BIO-Europe 2009
02 November 2009, Vienna, Austria - November 2-4, 2009
BioPartnering Europe
11 October 2009, London, United-Kingdom - October 11-14, 2009
Midcap Event
21 September 2009, Paris, France, 21 - 22 September
Presentation of 2009 half-year consolidated results
27 August 2009, Conference call in English at 11.30 am
36th Annual Meeting and Exposition of the Controlled Release Society - Poster: " Optimization and in vivo evaluation of an oral Irinotecan-loaded Sustained Release Nanoparticles formulation"
18 July 2009, July 18 - 22, 2009 - Bella Center, Copenhagen, Denmark
Euro-BioTech Forum
29 June 2009, June 29 - July 1st, 2009 - Hotel Arts Barcelona, Spain
XVIII International HIV Drug Resistance Workshop - Oral communication and poster: "New integrase binding inhibitors acting in synergy with Raltegravir"
12 June 2009, June 8-12, 2009 - Fort Myers, Florida, USA
2nd Pharmaceutical Sciences Fair and Exhibition, PharmSciFair - Oral communication: "Sustained Release Nanoparticles (SRN) for oral administration of Irinotecan"
10 June 2009, June 8-12, 2009 - Nice, France
BioEquity Europe
09 June 2009, Hilton Munick Park Hotel, Munich, Allemagne
The 2009 American Society of Clinical Oncology (ASCO) Annual Meeting - Abstract: "Prevalence and management of oropharyngeal candidiasis (OPC) by medical and radiation oncologists in cancer patients"
29 May 2009, May 29 - June 2, 2009 - Orlando, Florida, USA
American Society of Gene Therapy (ASGT) 12th Annual Meeting - Presentation of a poster: "Complete Melanoma Regressions after Electrotransfer of the p-AMEP(TM) Plasmid Coding for an Anti-Angiogenic and Anti-Metastatic Peptide"
28 May 2009, May 27-30, 2009 - San Diego, California, USA
2009 BIO International Convention
18 May 2009, Atlanta, Georgia - USA - May 18-21,2009
The American Conference for the Treatment of HIV (ACTHIV) - Presentation of a poster: "Once-Daily Miconazole Mucoadhesive Buccal Tablet is an Effective and Safe Treatment for Oropharyngeal Candidiasis"
15 May 2009, May 15-17, 2009, Denver, Colorado
Annual General Meeting
29 April 2009, Company's head office, Paris, France
SmallCap Event
27 April 2009, Paris, France, 27 - 28 April
BioCapital Europe 2009
21 April 2009, Amsterdam, The Netherlands
AACR 100th Annual Meeting 2009 (American Association for Cancer Research) Presentation of two abstracts: p-AMEP(TM), an anti-angiogenic and anti-invasive biotherapy for Metastatic Melanoma treatment; Oral Irinotecan Nanoparticles for the treatment of advanced colorectal cancer
18 April 2009, April 18-22, 2009 - Colorado Convention Center, Denver, Colorado
BIO-Europe Spring 2009
16 March 2009, Milano Convention Center (MIC) Milano, Italy - March 16-18, 2009
SFAF analyst meeting : presentation of the consolidated accounts for 2008
06 March 2009, Company's head office, Paris, France
16th Conference on Retroviruses and Opportunistic Infections: Presentation of a poster on a new quinoleine family of HIV integrase inhibitors
08 February 2009, Montreal, Canada - February 8-11, 2009
27th J.P. Morgan Healthcare Conference
12 January 2009, San Francisco, Cal, USA - January 12-15, 2009
Presentation of an abstract on p-AMEP(TM), a biotherapy for metastatic melanoma
15 December 2008, Journées Scientifiques du Cancéropôle Ile-de-France (15 - 17 December, 2008), Cité Universitaire Internationale, Paris, France
Arkeon Finance small & midcap forum
18 November 2008, Paris, France
Bio Europe
17 November 2008, Mannheim/Heidelberg, Germany - 17-19 November
BioPartnering Europe
12 October 2008, London, UK - 12-14 October
EuroBio
07 October 2008, Paris, France - 7-9 October
MidCap Event
29 September 2008, Paris, France
ESMO - European Society of Medical Oncology
12 September 2008, Stockholm, Sweden - 12-16 September
Presentation of 2008 half-year consolidated results
28 August 2008, Conference call in English at 11.30 am, 28 August 2008